Home
Focus & approach
Dare
Build
Criteria
Portfolio
Team & Partners
Team Investment Management
Advisory board
Partners
vacancies
News & Events
News
Media
Events
Impact & ESG
Impact & ESG
impact Committee
Contact
Home
Focus & approach
Dare
Build
Criteria
Portfolio
Team & Partners
Team Investment Management
Advisory board
Partners
vacancies
News & Events
News
Media
Events
Impact & ESG
Impact & ESG
impact Committee
Contact
News archive
Featured
FundaMental Pharma appoints Dr. Dirk Beher as Chief Executive Officer
Meet Tyler Hayes, Principal at Thuja
FundaMental Pharma GmbH announces publication of a groundbreaking Proof-of-Concept Study in Cell Reports Medicine
Thuja promotes Eleanor Price to Associate
Meet Aartie Nanda, office & communication manager at Thuja
Thuja Capital co-leads a €12M Seed investment in Artica Therapeutics.
Synerkine Pharma secures EUR 12.1 million to accelerate novel pain therapeutics towards clinical proof-of-concept
Thuja invests in Gradient Denervation Technologies
Meet our new Investment Director and Partner Evan Castiglia
First patient receiving groundbreaking neuromodulation solution for severe migraine and cluster headaches
AstriVax Awarded €2.5 million Grant to Advance Innovative Vaccine Platform
Pan Cancer T appoints Rachel Abbott to succeed Katrien Reynders-Frederix as Chief Executive Officer